ABCC5, ERCC2, XPA and XRCC1 transcript abundance levels correlate with cisplatin chemoresistance in non-small cell lung cancer cell lines

BACKGROUND: Although 40–50% of non-small cell lung cancer (NSCLC) tumors respond to cisplatin chemotherapy, there currently is no way to prospectively identify potential responders. The purpose of this study was to determine whether transcript abundance (TA) levels of twelve selected DNA repair or m...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Weaver, David A, Crawford, Erin L, Warner, Kristy A, Elkhairi, Fadel, Khuder, Sadik A, Willey, James C
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2005
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1156938/
https://ncbi.nlm.nih.gov/pubmed/15882455
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-4-18
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares